Company intelligence / Profile preview

Yonghua Capital

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Yonghua Capital is an active, Shanghai-based investment management firm specializing in private equity and venture investments, with a significant focus on healthcare, biotechnology, and life sciences among broader interests in advanced manufacturing, IT, and new energy. The firm provides capital to high-growth companies, particularly in China, and has invested in over 80 enterprises, more than 40 of which have reached IPO.

Industry: Investors

Partnerships

Angitia BiopharmaceuticalsImmViraLyndra Therapeutics

Beyond the preview

Go deeper on Yonghua Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yonghua Capital.

Explore the full profile